What is the primary factor that determines whether a form of ephedrine is considered a dangerous drug?

The primary factor that determines whether a form of ephedrine is considered a dangerous drug is the concentration of ephedrine. In pharmaceutical regulation, particularly in the context of controlled substances and dangerous drugs, the concentration of the active ingredient is crucial. Higher concentrations can lead to increased risk of abuse, dependence, and potential for misuse, which categorizes the substance differently under regulatory standards.

In New Mexico, the classification of drugs often hinges on both their potential for abuse and their concentration, with stricter controls placed on more potent formulations. This regulatory framework is designed to protect public health by limiting access to substances that possess higher risks when misused.

The method of administration, intended use, and FDA approval status do play roles in the broader context of drug regulation, but they do not directly influence the classification of ephedrine as dangerous in the same way that concentration does. Method and use are more about the implications of the drug in practice, while FDA approval indicates a level of safety and efficacy but does not determine whether a drug is dangerous or not under various circumstances.